ICU Management of Acute Liver Failure

Clinics in Chest Medicine

Volumn 30, Issue 1, 2009, Pages 71-87

  Schilsky, Michael L ^a,b   Honiden, Shyoko ^a,b   Arnott, Lindsay ^b   Emre, Sukru ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale New Haven Transplantation Center   (United States)

Author keywords

Acute liver failure; Cerebral edema; Coagulopathy; Hypothermia; Liver assist devices; Liver transplant

Indexed keywords

ACETYLCYSTEINE; AMIODARONE; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; BARBITURIC ACID DERIVATIVE; COPPER; CORTICOSTEROID; CORTICOTROPIN; DISULFIRAM; FENTANYL; GLUCOSE; HALOTHANE; HYPERTENSIVE AGENT; INDOMETACIN; ISONIAZID; KETOCONAZOLE; MANNITOL; MORPHINE; PARACETAMOL; PENICILLIN G; PETHIDINE; PHENYTOIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SILIBININ; STEROID; UNINDEXED DRUG; VALPROIC ACID; VITAMIN K GROUP; ZINC;

ADRENAL INSUFFICIENCY; ALBUMIN DIALYSIS; ALCOHOL LIVER CIRRHOSIS; ALLERGY; AMANITA PHALLOIDES; ANALGESIA; ARTIFICIAL VENTILATION; AUTOIMMUNE HEPATITIS; BLEEDING; BLOOD CLOTTING DISORDER; BRAIN EDEMA; BRAIN HEMORRHAGE; BUDD CHIARI SYNDROME; CHELATION THERAPY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; CONSULTATION; CONTINUOUS HEMOFILTRATION; CYTOMEGALOVIRUS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FATTY LIVER; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART DISEASE; HELLP SYNDROME; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HEPATITIS; HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS E VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HYPERCOAGULABILITY; HYPEREMIA; HYPOFIBRINOGENEMIA; HYPOGLYCEMIA; HYPOTHERMIA; IMMUNE MEDIATED INJURY; INDUCED HYPOTHERMIA; INFECTION; INTENSIVE CARE; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; KIDNEY FAILURE; LABORATORY TEST; LIVER BIOPSY; LIVER FAILURE; LIVER ISCHEMIA; LIVER SUPPORT; LIVER TOXICITY; LIVER TRANSPLANTATION; METABOLIC DISORDER; MULTIPLE ORGAN FAILURE; NUTRITION; NUTRITIONAL REQUIREMENT; OUTCOME ASSESSMENT; PAIN; PATHOGENESIS; PATIENT ASSESSMENT; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RESPIRATORY FAILURE; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SEIZURE; SEPTIC SHOCK; SINGLE DRUG DOSE; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; TOXICOKINETICS; VARICELLA ZOSTER VIRUS; VASCULAR ACCESS DEVICE; VEIN CATHETERIZATION; VIRUS HEPATITIS; VITAMIN K DEFICIENCY; WILSON DISEASE;

BLOOD COAGULATION DISORDERS; CRITICAL CARE; HUMANS; HYPOTHERMIA, INDUCED; INTENSIVE CARE UNITS; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; NUTRITIONAL SUPPORT; REFERRAL AND CONSULTATION; SHOCK;

EID: 58749089323     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.10.001     Document Type: Review

References (85)

1. Trey, and Davidson. The management of fulminant hepatic failure. Prog Liver Dis 3 (1970) 282-298
2. Rutherford A., and Chung R.T. Acute liver failure: mechanisms of hepatocytes injury and regeneration. Semin Liver Dis 28 (2008) 167-174
3. Strand S., Hofmann W.J., Grambihler A., et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas)-mediated apoptosis. Nat Med 4 (1998) 588-593
4. Trost L.C., and Lemasters J.J. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome. Toxicol Appl Pharmacol 147 (1997) 431-441
5. Smilkstein M.J., Knapp G.L., Kulig K.W., et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 319 (1988) 1557-1562
6. Hawker F. Liver dysfunction in critical illness. Anaesth Intensive Care 19 (1991) 165-181
7. Lindros K. Ozonation of cytochrome P450 expression, drug metabolism, and toxicity in liver. Gen Pharmacol 28 (1997) 191-196
8. Ostapowicz G., Fontana R.J., Schiødt F.V., et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137 (2002) 947-954
9. Polson J., and Lee W.M. Etiologies of acute liver failure: location, location, location. Liver Transpl 13 (2007) 1362-1363
10. Prescott L.F. Paracetamol, alcohol and the liver. Br J Clin Pharmacol 49 (2000) 291-301
11. Lieber C.S. Susceptibility to alcohol-related liver injury. Alcohol Alcohol Suppl 2 (1994) 315-326
12. Pearce B., and Grant I.S. Acute liver failure following therapeutic paracetamol administration in patients with muscular dystrophies. Anaesthesia 63 (2008) 89-91
13. Miners J.O., Drew R., and Birkett D.J. Mechanism of action of paracetamol protective agents in mice in vivo. Biochem Pharmacol 33 (1984) 2995-3000
14. Davern T.J., James L.P., Hinson J., et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 130 (2006) 687-694
15. Perry H.E., and Shannon M.W. Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 132 1 (1998) 149-152
16. Ekins B.R., Ford D.C., Thompson M.I., et al. The effect of activated charcoal on N-acetylcysteine absorption in normal subjects. Am J Emerg Med 5 (1987) 483-487
17. Broussard C.N., Aggarwal A., Lacey S.R., et al. Mushroom poisoning-from diarrhea to liver transplantation. Am J Gastroenterol 96 (2001) 3195-3198
18. Floersheim G.L., Eberhard M., Tschumi P., et al. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of amanita phalloides. Toxicol Appl Pharmacol 46 (1978) 455-462
19. Abboud G., and Kaplowitz N. Drug-induced liver injury. Drug Saf 30 (2007) 277-294
20. Trey C., Lipworth L., Chalmers T.C., et al. Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med 279 (1968) 798-801
21. Kumar M., Satapathy S., Monga R., et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 45 (2007) 97-101
22. HBV acute ALFSG experience. In press.
23. Lettau L.A., McCarthy J.G., Smith M.H., et al. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med 317 20 (1987) 1256-1262
24. Patra S., Kumar A., Trivedi S.S., et al. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann Intern Med 147 (2007) 28-33
25. Navaneethan U., Al Mohajer M., and Shata M.T. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 9 (2008) 1190-1199
26. Feranchak A.P., Tyson R.W., Narkewicz M.R., et al. Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature. Liver Transpl Surg 4 (1998) 469-476
27. Roberts E., and Schilsky M.L. A practice guideline on Wilson disease. Hepatology 47 (2008) 2089-2111
28. Sokol R.J., Francis P.D., Gold S.H., et al. Orthotopic liver transplantation for acute fulminant Wilson disease. J Pediatr 107 (1985) 549-552
29. Korman JD, Volenberg I, Balko J, et al. Screening for Wilson disease in acute liver failure by serum testing: a comparison of currently used tests. Hepatology 4:1030-2.
30. Castro M.A., Fassett M.J., Reynolds T.B., et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 181 (1999) 389-395
31. Ibdah J.A., Bennett M.J., Rinaldo P., et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340 (1999) 1723-1731
32. Martin Jr. J.N., Briery C.M., Rose C.H., et al. Postpartum plasma exchange as adjunctive therapy for severe acute fatty liver of pregnancy. J Clin Apher 23 4 (2008) 138-143
33. Barton J.R., and Sibai B.M. Care of the pregnancy complicated by HELLP syndrome. Gastroenterol Clin North Am 21 (1992) 937-950
34. Ochs A., Sellinger M., Haag K., et al. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 18 (1993) 217-225
35. Orloff M.J., Daily P.O., Orloff S.L., et al. A 27-year experience with surgical treatment of Budd-Chiari syndrome. Ann Surg 232 3 (2000) 340-352
36. Menon K.V., Shah V., and Kamath P.S. The Budd-Chiari syndrome. N Engl J Med 350 (2004) 578-585
37. Patel R.K., Lea N.C., Heneghan M.A., et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 130 (2006) 2031-2038
38. Ebert E.C. Hypoxic liver injury. Mayo Clin Proc 81 (2006) 1232-1236
39. Reiss U., Cowan M., McMillan A., et al. Hepatic veno-occlusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 24 (2002) 746-750
40. Alexopoulou A., Koskinas J., Deutsch M., et al. Acute liver failure as the initial manifestation of hepatic infiltration by a solid tumor: report of 5 cases and review of the literature. Tumori 92 (2006) 354-357
41. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 354 (2006) 54-66
42. Nilson L., Barregård L., and Bäckman L. Trail making test in chronic toxic encephalopathy: performance and discriminative potential. Clin Neuropsychol 13 3 (1999) 314-327
43. O'Grady J.G., Alexander G.J., Hayllar K.M., et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97 (1989) 439-445
44. Dhawan A., Taylor R.M., Cheeseman P., et al. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation. Liver Transpl 11 (2005) 441-448
45. Schiødt F.V., Bangert K., Shakil A.O., et al. Predictive value of actin-free Gc-globulin in acute liver failure. Liver Transpl 13 (2007) 1324-1329
46. Gow P.J., Sood S., and Angus P.W. Serum phosphate as a predictor of outcome in acetaminophen-induced fulminant hepatic failure. Hepatology 37 (2003) 711-712
47. Allocation of livers. Available at:. www.unos.org/PoliciesandBylaws2/policies/pdfs/policy_8.pdf Accessed November 26, 2008
48. Clemmesen J.O., Larsen F.S., Kondrup J., et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 29 (1999) 648-653
49. Tofteng F., Hauerberg J., Hansen B.A., et al. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 26 (2006) 21-27
50. Stravitz R.G., Lee W.M., Kramer A.H., et al. Therapeutic hypothermia for acute liver failure: toward a randomized, controlled trial in patients with advanced hepatic encephalopathy. Neurocrit Care 9 (2008) 90-96
51. Munoz S.J., Robinson M., Northrup B., et al. Elevated intracranial pressure and computed tomography of the brain in fulminant hepatocellular failure. Hepatology 13 (1991) 209-212
52. Vaquero J., Fontana R.J., Larson A.M., et al. Complications and use of intracranial pressure monitering in patients with acute liver failure and severe encephalopathy. Liver Transpl 11 (2005) 1581-1589
53. Shami V.M., Caldwell S.H., Hespenheide E.E., et al. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared to conventional therapy. Liver Transpl 9 (2003) 138-143
54. Vaquero J., Rose C., and Butterworth R.F. Keeping cool in acute liver failure: rationale for the use of mild hypothermia. J Hepatol 43 (2005) 1067-1077
55. Winney R.J., Kean D.M., Best J.J., et al. Changes in brain water with haemodialysis. Lancet 9 (1986) 1107-1108
56. Murphy N., Auzinger G., Bernel W., et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39 (2004) 464-470
57. Jalan R., Damink S.W., Deutz N.E., et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 354 (1999) 1164-1168
58. Jalan R., Damink S.W., Deutz N.E., et al. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127 (2004) 1338-1346
59. Vaquero J., and Blei A.T. Mild hypothermia for acute liver failure: a review of mechanisms of action. J Clin Gastroenterol 39 Suppl 2 (2005) S147-S157
60. Jalan R. Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. Semin Liver Dis 23 (2003) 271-282
61. Ellis A.J., Wendon J.A., and Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 32 (2000) 536-541
62. Bhatia V., Batra Y., and Acharya S.K. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J Hepatol 41 (2004) 89-96
63. Baldwin M., and Frost L.L. Effect of hypothermia on epileptiform activity in the primate temporal lobe. Science 124 (1956) 931-932
64. Liu Z., Gatt A., Mikati M., et al. Effect of temperature on kainic acid-induced seizures. Brain Res 631 (1993) 51-58
65. Ede R.J., Gimson A.E., Bihari D., et al. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 2 (1986) 43-51
66. Wijdicks E.F.M., and Nyberg S.L. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 34 (2002) 1220-1222
67. Harry R., Auzinger G., and Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int 23 (2003) 71-77
68. Harry R., Auzinger G., and Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 36 (2002) 395-402
69. Chung C., Gottstein J., Vaquero J., et al. Vasopressin infusion accelerates the development of brain edema in rats after portacaval anastomosis. Hepatology 36 (2002) 380A
70. Eefsen M., Dethloff T., Frederisen J.H., et al. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure, and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol 47 (2007) 381-386
71. Rolando N., Harvey F., Brahm J., et al. Prospective study of bacterial infection in acute liver failure. Hepatology 11 (1990) 49-53
72. Vaquero J., Polson J., Chung C., et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125 (2003) 755-764
73. Parekh N.K., Hynan L.S., De Lemos J., et al. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure?. Hepatology 45 (2007) 1489-1495
74. 1) in severe acute liver disease. J Hepatol 42 (2005) 365-370
75. Rolando N., Philpott-Howard J., and Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis 16 (1996) 389-402
76. Rolando N., Harvey F., Brahm J., et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 12 (1991) 1-9
77. Rolando N., Gimson A., Wade J., et al. Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 17 (1993) 196-201
78. Kodakat S., Gopal P., and Wendon J. Hyperglycemia is associated with intracranial hypertension in patients with acute liver failure. Liver Transpl 7 (2001) C21
79. Walsh T.S., Wigmore S.J., Hopton P., et al. Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med 28 (2000) 649-654
80. Salvino R., Ghanta R., Seidner D.L., et al. Liver failure is uncommon in adults receiving long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 30 (2006) 202-208
81. Stadlbauer V., and Jalan R. Acute liver failure: liver support therapies. Curr Opin Crit Care 13 (2007) 215-221
82. Curr Opinion.
83. Skwarek A., Grodzicki M., Nyckowski P., et al. The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. Transplant Proc 38 (2006) 209-211
84. Sen S., Felldin M., Steiner C., et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson's disease. Liver Transpl 8 (2002) 962-967
85. Farmer D.G., Anselmo D.M., Ghobrial R.M., et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Annals of Surgery 237 (2003) 666-676